Research on complementary/alternative medicine for patients with breast cancer: A review of the biomedical literature

Journal of Clinical Oncology

Volumn 18, Issue 3, 2000, Pages 668-683

  Jacobson, Judith S ^a   Workman, Sara B ^a   Kronenberg, Fredi ^a  

^a Division of EpidemiologySchool of Public Health Herbert Irving Comprehensive Cancer Center and Center for Complementary and Alternative Medicine Research in Women's Health Department of Rehabilitation Medicine College of Physicians and Surgeons Columbia University New York NY ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTON A5; ARGININE; ASCORBIC ACID; BETA CAROTENE; FOLIC ACID; GAMMA INTERFERON; GAMMA LINOLENIC ACID; HYDRAZINE SULFATE; LAETRILE; MELATONIN; NICOTINAMIDE; OMEGA 3 FATTY ACID; RETINOL PALMITATE; SELENIUM; TAMOXIFEN; UBIDECARENONE; VISCUM ALBUM EXTRACT;

ACUPUNCTURE; ALTERNATIVE MEDICINE; ARTICLE; BREAST CANCER; CLINICAL RESEARCH; CLINICAL TRIAL; DATA BASE; DIET THERAPY; FAMILY THERAPY; FEEDBACK SYSTEM; HERBAL MEDICINE; HUMAN; HYPNOSIS; IMMUNE SYSTEM; LYMPHEDEMA; MASSAGE; MEDICAL LITERATURE; MEDITATION; MUSIC THERAPY; NAUSEA; PRIORITY JOURNAL; PSYCHOTHERAPY; SYMPTOM; YOGA;

EID: 0033961105     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.2000.18.3.668     Document Type: Article

References (85)

1. Newman V, Rock CL, Faerber S, et al: Dietary suplement use by women at risk for breast cancer recurrence: The women's healthy eating and living study group. J Am Diet Assoc 98:285-292, 1998
2. Risberg T, Lund E, Wist E, et al: Cancer patients use of unproven therapy: A 5-year follow-up study. J Clin Oncol 16:6-12, 1998
3. Beisecker A, Cook MR, Ashworth J, et al: Side effects of adjuvant chemotherapy: Perceptions of node-negative breast cancer patients. Psychooncology 6:85-93, 1997
4. Wallgren A: Late effects of radiotherapy in the treatment of breast cancer. Acta Oncol 31:237-242, 1992
5. Gyenes G, Fornander T, Carlens P, et al: Morbidity of ischemic heart disease in early breast cancer 15-20 years after adjuvant radio-therapy. Int J Radiat Oncol Biol Phys 28:1235-1241, 1994
6. Irvine D, Brown B, Crooks D: Psychosocial adjustment in women with breast cancer. Cancer 67:1097-1117, 1991
7. Workshop on Alternative Medicine: Alternative Medicine: Expanding Medical Horizons - A report to the National Institutes of Health on Alternative Medical Systems and Practices in the United States. Washington, DC, National Institutes of Health, 1994
8. Quan N, Zhang Z, Demetrikopoulos MK, et al: Evidence for involvement of B lymphocytes in the surveillance of lung metastasis in the rat. Cancer Res 59:1080-1089, 1999
9. Emtage PCR, Wan Y, Hitt M, et al: Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models. Hum Gene Ther 10:697-709, 1999
10. Lissoni P, Barni S, Tancini G, et al: A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma. Br J Cancer 69:196-199, 1994
11. Spiegel D, Bloom JR, Kraemer HC, et al: Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 2:888-891, 1989
12. Brittenden J, Park GM, Heys SD, et al: L-Arginine stimulates host defenses in patients with breast cancer. Surgery 115:205-212, 1994
13. Bagenal FS, Easton DF, Harris E, et al: Survival of patients with breast cancer attending Bristol Cancer Help Centre. Lancet 336:606-610, 1990
14. Heyse-Moore L, Wright S, Monro J, et al: Bristol Cancer Help Centre. Lancet 336:743-744, 1990 (letter)
15. Tobias JS, Baum M: Bristol Cancer Help Centre. Acta Oncol 336:1323, 1990 (letter)
16. Bourke I, Goodare H: Bristol Cancer Help Centre. Lancet 338:1401-1402, 1990 (letter)
17. Hoffer A, Pauling L: Hardin Jones biostatistical analysis of mortality data for a second set of cohorts of cancer patients with a large fraction surviving at the termination of the study and a comparison of survival times of cancer patients receiving large regular doses of vitamin C and other nutrients with similar patients not receiving these doses. J Orthomol Med 8:157-167, 1993
18. McDermott MM, Schmitt B, Wallner E: Impact of medication nonadherance on coronary heart disease outcomes: A critical review. Arch Intern Med 157:1921-1929, 1997
19. Filshie J, Redman D: Acupuncture and malignant pain problems. Eur J Surg Cancer 11:389-394, 1985
20. Chengjiang H, Kehui G, Qunzhu X, et al: Effects of microwave acupuncture on the immunological function of cancer patients. J Tradit Chin Med 7:9-11, 1987
21. Jacobson JS: Report of the National Workshop on Research Methodologies for Unconventional Therapies, sponsored by the Candian Breast Cancer Initiative. J Altern Complement Med 2:541-542, 1996
22. Baum M: Breast cancer 2000 BC to 2000 AD: Time for a paradigm shift? Acta Oncol 32:3-8, 1993
23. Cunliffe J: Morphostasis and immunity. Med Hypotheses 44: 89-96, 1995
24. Moss RW: The Cancer Industry: New Updated Edition. Brooklyn, NY, Equinox Press, 1996
25. United States General Accounting Office: Cancer Drug Research: Contrary to Allegation, NIH Hydrazine Sulfate Studies Were Not Flawed. Washington, DC, United States General Accounting Office, 1998
26. Newton BW: The use of hypnosis in the treatment of cancer patients. Am J Clin Hypn 25:104-113, 1983
27. Clover A, Last P, Fisher RA: Complementary anticancer therapy: A pilot study of patients, therapy and quality of life. Complement Ther Med 3:129-133, 1995
28. Lissoni P, Barni S, Ardizzoia A, et al: A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms. Cancer 73:699-701, 1994
29. Lissoni P, Barni S, Meregalli S, et al: Modulation of cancer endocrine therapy by melatonin: A phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. Br J Cancer 71:854-856, 1995
30. Wilson ST, Blask DE, Lemus-Wilson AM: Melatonin augments the sensitivity of MCF-7 human breast cancer cells to tamoxifen in vitro. J Clin Endocrinol Metab 75:669-670, 1992
31. Bartsch H, Bartsch C, Simon WE, et al: Antitumor activity of the pineal gland: Effect of unidentifird substances versus the effect of melatonin. Oncology 49:27-30, 1992
32. Henkel G: The status of oncology research in complementary & alternative medicine: Attitudes changing at government & practice levels. Oncol Times 19:55-60, 1999
33. Kinlen LJ: Immunologic factors, including AIDS, in Schottenfeld D, Fraumeni JF (eds): Cancer Epidemiology and Prevention (ed 2). New York, NY, Oxford, 1996, pp 532-545
34. van der Pompe G, Antoni M, Visser A, et al: Adjustment to breast cancer: The psychobiological effects of psychosocial interventions. Patient Educ Couns 28:209-219, 1996
35. Andersen BL, Farrar WB, Golden-Kreutz D, et al: Stress and immune responses after surgical treatment for breast cancer. J Natl Cancer Inst 90:30-36, 1998
36. Redondo M, Concha A, Ruiz-Cabello F, et al: Class I major histocompatibility complex antigens and tumor ploidy in breast and bronchogenic carcinomas. Cancer Detect Prev 21:22-28, 1997
37. Singh A, Purohit A, Duncan LJ, et al: Control of aromatase activity in breast tumors: The role of the immune system. J Steroid Biochem Mol Biol 61:185-192, 1997
38. Fawzy FI, Fawzy NW, Hyun CS: Malignant melanoma: Effects of an early structured psychiatric intervention, coping and affective state on recurrence and survival six years later. Arch Gen Psychiatry 50:681-689, 1993
39. Stewart TH, Heppner GH: Immunological enhancement of breast cancer. Parasitology 115:S141-S153, 1997 (suppl)
40. Curt GA: Investment in research as a national priority. Oncologist 3:64-66, 1998
41. Fontanarosa PB, Lundberg GD: Complementary, alternative, unconventional, and integrative medicine: Call for papers for the annual coordinated theme issues of the AMA journals. JAMA 278: 2111-2112, 1997
42. Area hospitals going holistic. Crain's Health Pulse February 22, 1999
43. Bensoussan A, Talley NJ, Hing M, et al: Treatment of irritable bowel syndrome with Chinese herbal medicine: A randomized controlled trial. JAMA 280:1585-1589, 1998
44. Rosenbaum PR, Rubin DB: Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 79:516-524, 1984
45. Rosenbaum PR: Discussing hidden bias in observational studies. Ann Intern Med 115:901-905, 1991
46. Hennekens CH, Buring JE: Observational evidence. Ann N Y Acad Sci 703:18-24, 1993
47. Lockwood K, Moesgaard S, Hanioka T, et al: Apparent partial remission of breast cancer in 'high risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Mol Aspects Med 15:s231-s240, 1994
48. Recchia F, Rhea S, Pompili P, et al: Beta-interferon, retinoids and tamoxifen as maintenance therapy in metastatic breast cancer: A pilot study. Clin Ter 146:603-610, 1995
49. Recchia F, Sica G, De Filippis S, et al: Interferon-beta, retinoids and tamoxifen in the treatment of metastatic breast cancer: A phase 11 study. J Interferon Cytokine Res 15:605-610, 1995
50. Kovacs E, Hajto T, Hostanska K: Improvement of DNA repair in lymphocytes of breast cancer patients treated with Viscum album extract (Iscador). Eur J Cancer 27:1672-1676, 1991
51. Gellert GA, Maxwell RM, Siegel BS: Survival of breast cancer patients receiving adjunctive psychosocial support therapy: A 10-year follow-up study. J Clin Oncol 11:66-69, 1993
52. Morgenstern H, Gellert GA, Walter SD, et al: The impact of a psychosocial support program on survival with breast cancer. The importance of selection bias in program evaluation. J Chron Dis 37:273-282, 1984
53. Simonton OC, Matthews-Simonton S, Sparks TF: Psychological intervention in the treatment of cancer. Psychosomatics 21:226-231, 1980
54. Burzynski SR, Kubove E, Burzynsk, B: Phase I clinical studies of antineoplaston A5 injections. Drugs Exp Clin Res 13:37-43, 1987 (suppl 1)
55. Lissoni P, Barni S, Cattaneo G, et al: Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies. Oncology (Switzerland) 48:448-450, 1991
56. Moertel CG, Ames MM, Kovach JS, et al: A pharmacologic and toxicological study of amygdalin. JAMA 245:591-594, 1981
57. Moertel CG, Fleming TR, Rubin J, et al: A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. N Engl J Med 306:201-206, 1982
58. Kuttan R, Sudheeran PC, Josph CD: Turmeric and curcumin as topical agents in cancer therapy. Tumori 73:29-31, 1987
59. Sims S: Slow stroke back massage for cancer patients. Nurs Times 82:47-50, 1986
60. Arathuzik D: Effects of cognitive-behavioral strategies on pain in cancer patients. Cancer Nurs 17:207-214, 1994
61. Beck SL: The therapeutic use of music for cancer-related pain. Oncol Nurs Forum 18:1327-1337, 1991
62. Davis H: Effects of biofeedback and cognitive therapy on stress in patients with breast cancer. Psychol Rep 59:967-974, 1986
63. Spiegel D, Bloom JR: Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med 45:333-339, 1983
64. Chlebowsk, RT, Bulcavage L, Grosvenor M, et al: Hydrazine sulfate in cancer patients with weight loss. Cancer 59:406-410, 1987
65. Lissoni P, Barni S, Brivio F, et al: A biological study on the efficacy of low-dose subcutaneous interleukin-2 plus melatonin in the treatment of cancer-related thrombocytopenia. Oncology 52:360-362, 1995
66. Lissoni P, Paolorossi G, Tancini S, et al: Is there a role for melatonin in the treatment of neoplastic cachexia? Eur J Cancer 8:1340-1343, 1996
67. Black MM, Zachrau RE, Dion AS, et al: Stimulation of prognostically favorable cell-mediated immunity of breast cancer patients by high-dose vitamin A and vitamin E, in Prasad KN (ed): Vitamins, Nutrition, and Cancer. Basel, Switzerland/New York, NY, Karger, 1984, pp 134-146
68. Garritson BK, Nikaein A, Peters GN, et al: Effect of major dietary modifications on the immune system in patients with breast cancer: A pilot study. Cancer Pract 3:239-246, 1995
69. Beuth J, Ko HL, Gabius HJ, et al: Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients. Clin Invest 70:658-661, 1992
70. Hajto T, Lanzrein C: Natural killer and antibody-dependent cell-mediated cytotoxicity activities and large granular lymphocyte frequencies in Viscum album-treated breast cancer patients. Oncology 43:93-97, 1986
71. Hajto T: Immunomodulatory effects of iscador: A Viscum album preparation. Oncology 43:51-65, 1986 (suppl 1)
72. Heiny B-M, Beuth J: Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients. Anticancer Res 14:1339-1342, 1994
73. Hou J, Liu S, Ma Z, et al: Effects of gynostemma pentaphyllum makino on the immunological function of cancer patients. J Tradit Chin Med 11:47-52, 1991
74. Li Y, Yu G: A comparative clinical study on prevention and treatment with selected chronomedication of leukopenia induced by chemotherapy. J Tradit Chin Med 13:257-261, 1993
75. Gruber BL, Hersh SP, Hall NR, et al: Immunological responses of breast cancer patients to behavioral interventions. Biofeedback Self
76. Richardson MA, Post-White J, Grimm EA, et al: Coping, life attitudes, and immune responses to imagery and group support after breast cancer treatment. Altern Ther Health Med 3:62-70 1997
77. Loprinzi CL, Athmann LM, Kardinal CG, et al: Randomized trial of dietician counseling to try to prevent weight gain associated with breast cancer adjuvant chemotherapy. Oncology 53:228-232, 1996
78. Myers C, Bonow R, Palmeri S, et al: A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine. Semin Oncol 10:53-55, 1983
79. 6 acupuncture by acupressure in patients having cancer chemotherapy. J R Soc Med 83:360-362, 1990
80. Dundee JW, Ghaly RG, Fitzpatrick KTJ, et al: Acupuncture prophylaxis of cancer chemotherapy-induced sickness. J R Soc Med 82:69-271, 1989
81. Lundeberg T, Kjartansson J, Samuelsson U: Effect of electrical nerve stimulation on healing of ischaemic skin flaps. Lancet 2:712-714, 1988
82. Maiche AG, Grohn P, Maki-Hokkonen H: Effect of chamomile cream and almond ointment on acute radiation skin reaction. Acta Oncol 30:395-396, 1991
83. Hornsby R: The use of compression to treat lymphoedema. Prof Nurse 11:127-128, 1995
84. Zanolla R, Monzeglio C, Balzarini A, et al: Evaluation of the results of three different methods of postmastectomy lymphedema treatment. J Surg Oncol 26:210-213, 1984
85. Lissoni P, Tancini G, Barni S, et al: Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin. Support Care Cancer 5:126-129, 1997